← FDA Drug Approvals (Drugs@FDA)

EGATEN

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2019-02-13

Drug application

FDA Application #

NDA208711

Application type

New Drug Application

Brand name

EGATEN

Generic name

TRICLABENDAZOLE

Active ingredients

TRICLABENDAZOLE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

NOVARTIS

Manufacturer

Novartis Pharmaceuticals Corporation

First approval

2019-02-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown